Blood Cancer Journal is a peer-reviewed, open access online journal publishing pre-clinical and clinical work in the field of hematology with ramifications into translational biology research down to new therapies...
Via Krishan Maggon
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|
Citation: Blood Cancer Journal (2015) 5, e309; doi:10.1038/bcj.2015.30
Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testingPublished online 1 May 2015
OPEN
P O Pietarinen1, T Pemovska2, M Kontro1, B Yadav2, J P Mpindi2, E I Andersson1, M M Majumder2, H Kuusanmäki2, P Koskenvesa1, O Kallioniemi2, K Wennerberg2, C A Heckman2, S Mustjoki1,3 and K Porkka1,3
Correspondence: Dr K Porkka, Division of Hematology, Department of Medicine, Comprehensive Cancer Center, Helsinki University Hospital, University of Helsinki, PO Box 372, Haartmaninkatu 4, FIN-00290 Helsinki, Finland. E-mail: Kimmo.porkka@helsinki.fi